Results 191 to 200 of about 1,521,034 (349)

Restrictions on undocumented immigrants' access to health services: the public health implications of welfare reform.

American Journal of Public Health, 2003
J. Kullgren
semanticscholar   +1 more source

SPG4 and Dementia: Expanding the Clinical Spectrum

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing.
Emanuele Panza, Arun Meyyazhagan, Eliseo Picchi, Gustavo Ribas, Ingrid Faber, Ryosuke Miyamoto, Preethi Basavaraju, Paolo Eusebi, Haripriya Kuchi Bhotla, Mario Stasi, Fabrizio Gaudiello, Francesco Patti, Filippo Maria Santorelli, Marcondes Cavalcante França Jr, José Luiz Pedroso, Orlando Graziani Povoas Barsottini, Hélio Afonso Ghizoni Teive, Peter Henry St George‐Hyslop, Toshitaka Kawarai, Antonio Orlacchio   +19 more
wiley   +1 more source

Report from the Health Care Access Improvement Panel [2017]

, 2017
application/pdf; "May 2017.""2004 Senate Substitute for HB 2912 and House Substitute for SB 12 established the Health Care Access Improvement Program, which uses an annual assessment on inpatient services provided by hospitals to improve and expand ...
Health Care Access Improvement Panel (Kan.).
core  

Strategies, programs and interventions implemented to improve sex workers' access to health services in low- and middle-income countries: a scoping review. [PDF]

BMC Public Health
Garces-Palacio IC, Bedoya Mejía S, Sierra Ospina D, Bustamante Navarro V, Mejía Ochoa MS, Muñoz-Echeverri IF, Rojas Arbeláez CA, Castro Arroyave DM, Mojica Vélez CG, Posada Zapata IC.   +9 more
europepmc   +1 more source

Cancer survivorship experiences in Utah: an evaluation assessing indicators of survivors' quality of life, health behaviors, and access to health services. [PDF]

Cancer Causes Control, 2023
Millar MM, Herget KA, Ofori-Atta B, Codden RR, Edwards SL, Carter ME, Belnap B, Kirchhoff AC, Sweeney C.   +8 more
europepmc   +1 more source

Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone, Freddy Chafota, Miguel E. Rentería, Randi J. Hagerman, Ellery Santos, Anna Atkinson, Nicholas G. Martin, Elsdon Storey, Danuta Z. Loesch   +8 more
wiley   +1 more source

Community health insurance as a viable means of increasing access to health care for rural households in Uganda

, 2009
Includes abstract.Includes bibliographical references (p. 219-239).This study investigated the viability of community health insurance (CHI) as a means of increasing access to health care for rural households in Uganda.
Twikirize, Janestic Mwende
core  

Migration corridors in Africa and access to health services: Current challenges and a path forward for research and practice. [PDF]

J Public Health Afr
Kirumira E, Zaman MH, Lindsay HE, Pettengill J.   +3 more
europepmc   +1 more source

Use of Direct-to-Consumer Telemedicine to Access Mental Health Services. [PDF]

J Gen Intern Med, 2022
Hohman JA, Martinez KA, Anand A, Rood M, Martyn T, Rose S, Rothberg MB.   +6 more
europepmc   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source